12 Sep 2018

Life Sciences featured at the IDTechEx Show! Nov 14-15, CA
Independent analyst company, IDTechEx, will be highlighting life sciences with a selection of healthcare presentations at the forthcoming IDTechEx Show!, Nov 14-15 in CA.
12 Sep 2018

Life Sciences featured at the IDTechEx Show! Nov 14-15, CA
Independent analyst company, IDTechEx, will be highlighting life sciences with a selection of healthcare presentations at the forthcoming IDTechEx Show!, Nov 14-15 in CA.
12 Sep 2018

Life Sciences featured at the IDTechEx Show! Nov 14-15, CA
Independent analyst company, IDTechEx, will be highlighting life sciences with a selection of healthcare presentations at the forthcoming IDTechEx Show!, Nov 14-15 in CA.
11 Dec 2017

FDA approves first digital pill
FDA approves Abilify MyCite, a pill with a sensor that digitally tracks if patients have ingested their medication
12 Apr 2016

Sensors driving next-generation wearable devices
Sensor development is driving the next generation of wearable devices, and this development is now going further than simply attaching sensors to devices that can be stuck on the body
15 Oct 2015

IDTechEx Wearable USA - innovators, adopters and investors
IDTechEx Wearable USA - Bringing Innovators, Adopters And Investors in Technology Under One Roof. IDTechEx Wearable USA is the largest wearable technology event in the Americas. The two day conference and exhibition brings together leading authorities from key areas throughout the industry, as a large part of IDTechEx's 3000+ attendee, 200+ exhibitor co-located event series.
Background
28 Jan 2015

Vancive Medical Technologies
Vancive Medical Technologies are the Medical division of Avery Dennison. Their wearable electronics product is a disposable skin patch device that does activity and health monitoring. They work with partners that want to use the data produced by the device.
Full profile interview
24 Jan 2015

Proteus Digital Health
Proteus first received funding for research into digital healthcare projects in 2004. Based in Redwood City, CA, they now have over 200 employees and have worked on several collaborations, including with Novartis, Medtronic, Oracle and the NHS in the UK. They underwent rebranding in 2012, changing their name from Proteus Biomedical to Proteus Digital Health. They are a privately held company, and have received over $400 million in funding from sources including Carlyle, Essex Woodlands, Kaiser Permanente®, Medtronic®, Novartis®, Otsuka®, Oracle®, ON Semiconductor® and other investors.
Included are: